Regeneron Pharmaceuticals Inc REGN:NASDAQ

Last Price$373.53NASDAQ Previous Close - Last Trade as of 4:00PM ET 12/11/19

Today's Change+5.86(1.59%)
Bid (Size)$362.89 (1)
Ask (Size)$384.43 (1)
Day Low / High$368.25 - 376.68
Volume935.7 K
  • Latest Stories
  • Commentary and Analysis
Regeneron Pharma, Sanofi Reach Royalty-Based Agreement
10:01AM ET 12/10/2019 MT Newswires

Regeneron Pharmaceuticals (REGN) said Tuesday that it is restructuring its antibody collaboration with Sanofi for Kevzara (sarilumab) and Praluent...

Sanofi Discloses 21.6% Stake in Regeneron
4:21AM ET 12/10/2019 MT Newswires

French drug maker Sanofi (SNY) disclosed late Monday a 21.6% equity interest in US-based peer Regeneron Pharmaceuticals (REGN). Sanofi holds, both directly...

Stocks Break Three-Session Winning Streak as Investors Await Fed Meeting, Trade News
4:33PM ET 12/09/2019 MT Newswires

Stocks ended modestly lower Monday, as investors took a breather from three straight sessions of gains ahead of the Federal Reserve's two-day meeting this...

Regeneron Pharma Posts Positive Early Results from Initial REGN5458 Trial to Treat Multiple Myeloma
8:38AM ET 12/09/2019 MT Newswires

Regeneron Pharmaceuticals (REGN), a biotechnology company, said Sunday the first clinical data for REGN5458 have shown positive preliminary results in...

Regeneron Pharmaceuticals Posts Positive Topline Trial Results for Rare Blood Disorder Treatment Pozelimab
8:56AM ET 12/05/2019 MT Newswires

Regeneron Pharmaceuticals (REGN) on Thursday outlined positive topline results from its phase 2 clinical trial of pozelimab in treating paroxysmal...

Sector Update: Leading Health Care Stocks Mixed During Friday's Pre-Market Hours
9:21AM ET 11/29/2019 MT Newswires

Top Health Care Stocks: JNJ: +0.36% PFE: -0.05% ABT: Flat MRK: -0.62% AMGN: Flat The leading health care stocks were mixed during pre-market trading hours...

Regeneron's Ebola Drug Shows Among Highest Survival Rates in Study
4:12AM ET 11/29/2019 MT Newswires

Regeneron (REGN) said late Wednesday that its Ebola virus drug REGN-EB3 achieved among the highest survival rates among four treatments tested in a recent...

Stocks End Higher on Better-Than-Expected Economic Data, Trade Optimism
4:24PM ET 11/27/2019 MT Newswires

Stocks ended higher Wednesday as economic data indicated the US economy is continuing to expand and remarks from President Donald Trump the day before that...

Insider Trends: Regeneron Pharmaceuticals Insider Exercises Options Derivative Securities, Sells for Taxes and Self, Selling Trend Unaffected
4:32PM ET 11/26/2019 MT Newswires

On Nov 25, 2019, EVP Research and Development, Dr Neil Stahl, exercised options/derivative securities for 10,000 shares. A portion of these optioned shares...

Stocks End Higher, Boosted by Positive Trade News, Economic Data
4:39PM ET 11/22/2019 MT Newswires

Stocks ended higher Friday, boosted by remarks by President Donald Trump that the US and China are "very close" to a trade deal and positive economic data....